More substituted carbapenems designed at Merck for infections due to resistant pathogens Feb. 2, 2000
Cytoclonal reports design and development of new agents for rhinovirus and other viral infections Feb. 1, 2000
Another series of substituted carbapenems from Merck useful against resistant pathogens Jan. 31, 2000
RSS